Complement C5 and early oxygen kinetics during murine sepsis

Academic Emergency Medicine

Volumn 12, Issue 4, 2005, Pages 275-281

  Valencia, Gabriel ^a   Sarma, J Vidya ^a   Younger, John G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

C5a, anaphylatoxin; Open circuit calorimetry; Oxygen consumption; Respiratory exchange ratio

Indexed keywords

CARBON DIOXIDE; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A ANTIBODY; COMPLEMENT COMPONENT C5B; OXYGEN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; CALORIMETER; CECUM; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DRUG EFFECT; GENETIC DISORDER; INFLAMMATION; KINETICS; LETHAL DOSE; LIGATION; LUNG GAS EXCHANGE; MORTALITY; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PUNCTURE; SEPSIS; SURVIVAL RATE;

EID: 15944423245     PISSN: 10696563     EISSN: None     Source Type: Journal    
DOI: 10.1197/j.aem.2004.10.025     Document Type: Article

References (28)

1. D.C. Angus, W.T. Linde-Zwirble, G. Clermont, J. Carcillo, and M. Pinksy Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care Crit Care Med 29 2001 1303 1310
2. E. Rivers, B. Nguyen, and S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 349 2001 1368 1377
3. S. Moriyama, K. Okamoto, and Y. Tabira Evaluation of oxygen consumption and resting energy expenditure in critically ill patients with systemic inflammatory response syndrome Crit Care Med 27 1999 2133 2136
4. J. Siegel, F. Cerra, and B. Coleman Physiologic and metabolic correlations in human sepsis Surgery 86 1979 163 193
5. M. Reiss, and D. Roos Differences in oxygen metabolism of phagocytosing monocytes and neutrophils J Clin Invest 61 1978 480 488
6. J.A. Watts, and J.A. Kline Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury Acad Emerg Med 10 2003 985 997
7. S. Ebong, D. Call, J. Nemzek, G. Bolgos, D. Newcomb, and D. Remick Immunopathologic alterations in murine models of sepsis of increasing severity Infect Immun 67 1999 6603 6610
8. A.B. Lumb Nunn's Applied Respiratory Physiology 2000 Butterworth Heinemann Oxford, UK
9. B. Henderson, S. Poole, and M. Wilson Bacteria and cytokines: beyond lipopolysaccharide Bacteria-Cytokine Interactions in Health and Disease 1998 Portland Press Miami, FL 211 280
10. B. Henderson, S. Poole, and M. Wilson Lipopolysaccharides and cytokines: a tangled web. In: Bacteria-Cytokine Interactions in Health and Disease 1998 Portland Press Miami, FL pp 167-210
11. D. Bhole, and G.L. Stahl Therapeutic potential of targeting the complement cascade in critical care medicine Crit Care Med 31 suppl 2003 S97 S104
12. P.A. Ward The darkside of C5a in sepsis Nature Rev Immunol 4 2004 133 142
13. E.U. Hopken, L. Bao, N.P. Gerard, and C. Gerard The C5a chemoattractant receptor mediates mucosal defense to infection Nature 383 1996 86 89
14. J.G. Younger, S. Shankar-Sinha, and M. Mickiewicz Murine complement interactions with Pseudomonas aeruginosa and their effects during acute pneumonia Am J Respir Cell Mol Biol 29 2003 432 438
15. B.J. Czermak, V. Sarma, and C.L. Pierson Protective effects of C5a blockade in sepsis Nat Med 5 1999 788 792
16. J.G. Younger, N. Sasaki, and J. Delgado Systemic and lung physiological changes after intravascular activation of complement with cobra venom factor J Appl Physiol 90 2001 2289 2295
17. R.F. Guo, M. Huber-Lang, and X. Wang Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis J Clin Invest 106 2000 1271 1280
18. M.S. Huber-Lang, J.V. Sarma, and S.R. McGuire Protective effects of anti-C5a peptide antibodies in experimental sepsis FASEB J 15 2001 568 570
19. I.J. Laudes, J.C. Chu, and S. Sikranth Anti-C5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis Am J Pathol 160 2002 1867 1875
20. R.A. Wetsel, D.T. Fleischer, and D.L. Haviland Deficiency of the murine fifth complement component (C5): a 2-base pair gene deletion in a 5′-exon J Biol Chem 265 1990 2435 2440
21. W.H. Wheat, R. Wetsel, A. Falus, B.F. Tack, and R.C. Strunk The fifth component of complement (C5) in the mouse: analysis of the molecular basis of deficiency J Exp Med 165 1987 1442 1447
22. N.C. Riedemann, R.F. Guo, and T.A. Ne Increased C5a receptor expression in sepsis J Clin Invest 110 2001 101 108
23. J.G. Younger, N. Sasaki, and M.D. Waite Detrimental effects of complement activation in hemorrhagic shock J Appl Physiol 90 2000 441 446
24. S. Shankar-Sinha, G.A. Valencia, and B.K. Janes Klebsiella pneumoniae O-antigen contributes to bacteremia and lethality during murine pneumonia Infect Immun 72 2004 1423 1430
25. M.C. Cerquetti, D.O. Sordelli, J.A. Bellanti, and A.M. Hooke Lung defenses against Pseudomonas aeruginosa in C5-deficient mice with different genetic backgrounds Infect Immun 52 1986 853 857
26. L.T. Rosenberg, and D.K. Tachibana Mice deficient in C5 Progr Allergy 39 1986 169 191
27. M.S. Huber-Lang, N.C. Riedemann, and J.V. Sarma Protection of innate immunity by C5aR antagonist in septic mice FASEB J 16 2002 1567 1574
28. E.D. Verrier, S.K. Sherman, and K.M. Taylor Investigators Primo-CABG Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial JAMA 291 2004 2319 2327